Français

For Universal Life Investment Accounts

CI Global Health Sciences Corporate Class A

Sector Equity

As Of: Apr 30, 2020

Fund Objective

This fund's objective is to obtain maximum long-term capital growth. It invests primarily in equity and equity-related securities of companies around the world that specialize in the health care or medical industry. This includes companies that provide goods and services to these companies and companies that the portfolio advisor believes would benefit from developments in the health sciences industry.

Asset Allocation

Asset Percent
US Equity 63.80%
International Equity 31.45%
Cash and Equivalents 3.07%
Canadian Equity 1.68%

Sector Allocation

Sector Percent
Healthcare 82.37%
Consumer Services 7.91%
Financial Services 5.54%
Cash and Cash Equivalent 3.07%
Real Estate 1.11%

Geo Allocation

Region Percent
North America 68.55%
Europe 16.32%
Asia 14.03%
Latin America 1.11%
Other -0.01%

Top Holdings

Name Percent
Intercept Pharmaceuticals Inc 6.48%
Bristol-Myers Squibb Co 6.26%
Takeda Pharmaceutical Co Ltd 5.81%
Alexion Pharmaceuticals Inc 5.73%
Merit Medical Systems Inc 5.73%
Biogen Idec Inc 5.43%
CVS Health Corp 5.16%
SeaSpine Holdings Corp 4.92%
Ionis Pharmaceuticals Inc 4.91%
Fresenius Medical Care AG & Co KGaA 4.19%

Category

Sector Equity

General Info

Inception Date Jul 23, 1996
MER 2.38%
Total Assets
(in millions)
$176.42

UL Fees

Wave 33 or later
Life Dimensions (Low Fees) 1.00%
Life Dimensions 2.25%
Wealth Dimensions 1.00%
Wave 32 or earlier (2016 or earlier)
Life Dimensions 2.75%
Life Dimensions (Low Fees) 1.50%
UL Investment Loan Plan 2.75%
Ultimate Dimension 1.25%

Fund Management Company

CI Investments Inc

Investment Style

Large
Value
Large
Blend
Large
Growth
Mid
Value
Mid
Blend
Mid
Growth
Small
Value
Small
Blend
Small
Growth
;

Fund Growth

Growth Summary

Investment Value $68,337.17
Rate of Return +583.37%
Values over period specified.

Legend

CI Global Health Sciences Corporate Class A

S&P/TSX Composite Index TR


Performance

1 Mth 3 Mth 6 Mth YTD 1 Yr 3 Yr 5 Yr 10 Yr Inception
Fund 13.9 3.0 14.8 0.6 5.3 3.5 -0.2 11.7 8.4
S&P/TSX Composite Index TR 10.8 -13.9 -8.8 -12.4 -7.9 1.3 2.5 5.0 -
Quartile - - - - - - - - -

Calendar Performance

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund 12.0 1.1 6.4 -19.1 14.1 19.6 61.8 30.4 0.8 4.5
S&P/TSX Composite Index TR 22.9 -8.9 9.1 21.1 -8.3 10.6 13.0 7.2 -8.7 17.6
Quartile - - - - - - - - - -

Volatility

Volatility: 9

Risk vs. Return

CI Global Health Sciences Corporate Class A

Median

Other - Sector Equity

Risk & Tax Efficiency

3 Yr 5 Yr 10 Yr
Standard Deviation 16.83 17.97 16.25
Beta 0.74 0.75 0.65
Alpha 0.03 -0.01 0.09
R-Squared 0.46 0.30 0.21
Sharpe Ratio 0.21 0.03 0.71
Sortino Ratio 0.07 -0.19 0.80
Treynor 0.05 0.01 0.18
Tax Efficiency 71.97 - 91.00

Category

Sector Equity

General Info

Inception Date Jul 23, 1996
MER 2.38%
Total Assets
(in millions)
$176.42

UL Fees

Wave 33 or later
Life Dimensions (Low Fees) 1.00%
Life Dimensions 2.25%
Wealth Dimensions 1.00%
Wave 32 or earlier (2016 or earlier)
Life Dimensions 2.75%
Life Dimensions (Low Fees) 1.50%
UL Investment Loan Plan 2.75%
Ultimate Dimension 1.25%

Fund Management Company

CI Investments Inc

Investment Style

Large
Value
Large
Blend
Large
Growth
Mid
Value
Mid
Blend
Mid
Growth
Small
Value
Small
Blend
Small
Growth